Axsome Therapeutics, Inc. SEC filings AXSM
Axsome Therapeutics, Inc. has 672 filings in SEC EDGAR's recent list, going back to Jun 19, 2013. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 2, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 2, 2026 (results of operations, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 2, 2026 | Sep 30, 2026 |
| 10-Q | Quarterly report | Aug 10, 2026 | Jun 30, 2026 |
| 10-Q | Quarterly report | May 4, 2026 | Mar 31, 2026 |
| 10-Q | Quarterly report | Nov 3, 2025 | Sep 30, 2025 |
| 10-Q | Quarterly report | Aug 4, 2025 | Jun 30, 2025 |
| 10-Q | Quarterly report | May 5, 2025 | Mar 31, 2025 |
| 10-Q | Quarterly report | Nov 12, 2024 | Sep 30, 2024 |
| 10-Q | Quarterly report | Aug 5, 2024 | Jun 30, 2024 |
| 10-Q | Quarterly report | May 6, 2024 | Mar 31, 2024 |
| 10-Q | Quarterly report | Nov 6, 2023 | Sep 30, 2023 |
| 10-Q | Quarterly report | Aug 7, 2023 | Jun 30, 2023 |
| 10-Q | Quarterly report | May 9, 2023 | Mar 31, 2023 |
| 10-Q | Quarterly report | Nov 7, 2022 | Sep 30, 2022 |
| 10-Q | Quarterly report | Aug 9, 2022 | Jun 30, 2022 |
| 10-Q | Quarterly report | May 2, 2022 | Mar 31, 2022 |
| 10-Q | Quarterly report | Nov 8, 2021 | Sep 30, 2021 |
| 10-Q | Quarterly report | Aug 9, 2021 | Jun 30, 2021 |
| 10-Q | Quarterly report | May 10, 2021 | Mar 31, 2021 |
| 10-Q/A | Amended quarterly report | Nov 6, 2020 | Sep 30, 2020 |
| 10-Q | Quarterly report | Nov 5, 2020 | Sep 30, 2020 |
| 10-Q | Quarterly report | Aug 10, 2020 | Jun 30, 2020 |
| 10-Q | Quarterly report | May 11, 2020 | Mar 31, 2020 |
| 10-Q | Quarterly report | Nov 7, 2019 | Sep 30, 2019 |
| 10-Q | Quarterly report | Aug 8, 2019 | Jun 30, 2019 |
| 10-Q | Quarterly report | May 9, 2019 | Mar 31, 2019 |
| 10-Q | Quarterly report | Nov 9, 2018 | Sep 30, 2018 |
| 10-Q | Quarterly report | Aug 8, 2018 | Jun 30, 2018 |
| 10-Q | Quarterly report | May 8, 2018 | Mar 31, 2018 |
| 10-Q | Quarterly report | Nov 8, 2017 | Sep 30, 2017 |
| 10-Q | Quarterly report | Aug 9, 2017 | Jun 30, 2017 |
| 10-Q | Quarterly report | May 9, 2017 | Mar 31, 2017 |
| 10-Q | Quarterly report | Nov 14, 2016 | Sep 30, 2016 |
| 10-Q | Quarterly report | Aug 9, 2016 | Jun 30, 2016 |
| 10-Q/A | Amended quarterly report | Aug 9, 2016 | Mar 31, 2016 |
| 10-Q | Quarterly report | May 11, 2016 | Mar 31, 2016 |
Showing 35 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- AXSM (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New York, NY
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1579428
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.